- Report
- March 2024
- 102 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- January 2024
- 142 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- April 2023
- 107 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- January 2021
- 142 Pages
China, Global
From €3000EUR$3,383USD£2,663GBP
- Report
- January 2024
- 142 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- March 2022
- 87 Pages
Global
From €3500EUR$3,946USD£3,106GBP
- Report
- August 2021
- 138 Pages
Global
From €3200EUR$3,608USD£2,840GBP
- Report
- February 2023
- 349 Pages
Global
From €3392EUR$3,570USD£2,908GBP
- Report
- April 2023
- 147 Pages
Global
From €5699EUR$5,999USD£4,887GBP
Valacyclovir is an antiviral drug used to treat infections caused by certain types of viruses. It is primarily used to treat herpes virus infections, including herpes zoster (shingles), genital herpes, and herpes simplex virus (HSV) infections. Valacyclovir is also used to treat cold sores and to prevent recurrent outbreaks of genital herpes. Valacyclovir is available in both oral and intravenous forms.
Valacyclovir is a popular choice for treating infections caused by herpes viruses due to its high efficacy and low risk of side effects. It is also used to reduce the risk of transmission of genital herpes from an infected partner to an uninfected partner. Valacyclovir is generally well tolerated and is considered safe for long-term use.
Valacyclovir is a widely used drug in the infectious diseases drugs market. It is used to treat a variety of viral infections, including herpes virus infections, and is available in both oral and intravenous forms. Valacyclovir is generally well tolerated and is considered safe for long-term use.
Some companies in the Valacyclovir market include GlaxoSmithKline, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more